লোডিং…
Nanotherapeutics in transplantation: How do we get to clinical implementation?
Patients undergoing organ transplantation transition from one life‐altering issue (organ dysfunction) to a lifelong commitment—immunosuppression. Regimens of immunosuppressive agents (ISAs) come with significant side effects and comorbidities. Recently, the use of nanoparticles (NPs) as a solution t...
| প্রধান লেখক: | , , , , , |
|---|---|
| বিন্যাস: | Online প্রবন্ধ পাঠ্য |
| ভাষা: | English |
| প্রকাশিত: |
John Wiley and Sons Inc.
2022
|
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081154/ https://www.ncbi.nlm.nih.gov/pubmed/35224837 http://dx.doi.org/10.1111/ajt.17012 |